LEO
LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. Founded in 1908 and majority owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, and today, the company offers a wide range of therapies for all disease severities. LEO Pharma is headquartered in Denmark with a global team of 5,800 people, serving millions of patients across the world. In 2021, the company generated net sales of EUR 1,339 million.
LEO Pharma Hellas was founded in 1958, as one of the first four subsidiaries outside Denmark, and today is a leading pharmaceutical company in dermatological and antithrombotic products.
ABOUT LEO
More information about LEO Pharma Hellas can be found on the corporate website LEO-Pharma.gr
Related pages
YouTube: youtube.com/leopharmagreece
LinkedIn: linkedin.com/company/leo-pharma
Patient engagement websites
Skin conditions: psoriasis.myderma.info, atopic.myderma.info
Thrombosis: gateofthrombs.gr
Social Media: @psoriasis.myderma, @atopic.myderma, @gateofthrombs
CONTACT
- Website: LEO-Pharma.gr